B

Bestride

Asia, Beijing, China, Beijing

Description

Bestride Is an investment Firm.

Investor Profile

Bestride has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Therapeutics.

Stage Focus

  • Series D (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bestride frequently co-invest with?

Yuexiu Group
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
CCBT Private Equity
Asia, Beijing, China, Beijing
Co-Investments: 1
CE
Asia, Fujian, China, Xiamen
Co-Investments: 1
Dingxin Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
CS
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Exome Asset Management
North America, New York, United States, New York
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1

Which angels does Bestride often collaborate with?

SI
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Bestride?

IMPACT Therapeutics

Nanjing, Jiangsu, China

IMPACT Therapeutics is a therapeutics company dedicated to the development of similar drugs to treat cancer.

BiotechnologyPharmaceuticalTherapeutics
Series DMar 14, 2022

Find More Investors Like Bestride

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Bestride | Pipeseed